EP Patent

EP1272907A2 — Compliance tracking method

Assigned to Glaxo Group Ltd · Expires 2003-01-08 · 23y expired

What this patent protects

There is provided a method for automatically tracking compliance in a manufacturing process involving successive manufacturing operations comprising selecting an object; associating an identifier with said object, said identifier comprising a memory; performing a first manufactur…

USPTO Abstract

There is provided a method for automatically tracking compliance in a manufacturing process involving successive manufacturing operations comprising selecting an object; associating an identifier with said object, said identifier comprising a memory; performing a first manufacturing operation relating to the object; following the successful completion of said first manufacturing operation, writing an associated compliance data item to the memory; performing one or more further manufacturing operations relating to the object; and following the successful completion of each said further manufacturing operation or any package thereof, writing an associated compliance data item to the memory.

Drugs covered by this patent

Patent Metadata

Patent number
EP1272907A2
Jurisdiction
EP
Classification
—
Expires
2003-01-08
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.